The financial press is full of stories about Pfizer this morning, and its planned takeover of Astrazeneca. A recurring theme is the tax dimension of
Read the full article…
Richard Murphy
Support This Site
If you like what I do please support me on Ko-fi using credit or debit card or PayPal